Acquiring Company
Collagen Matrix
Acquired Company
Polyganics
Description
Collagen Matrix, Inc. ("Collagen Matrix"), a global leader in regenerative medicine and a Linden Capital Partners ("Linden") portfolio company, today announced the acquisition of Polyganics, B.V ("Polyganics"). Polyganics is a medical technology company that develops and manufactures bioresorbable medical devices. The acquisition expands Collagen Matrix's portfolio of bioresorbable solutions and technology platforms for bone and tissue repair, unlocking new markets and clinical opportunities for the Company.
Quick answer
Collagen Matrix is acquiring Polyganics, announced October 5, 2022.
- How much did Collagen Matrix pay for Polyganics?
- The deal value was not disclosed.
- What does Collagen Matrix do?
- Collagen Matrix, Inc. is a developer and manufacturer of collagen-based medical products used for tissue and bone repair and regeneration.
Source: Fundz verified event record.
Who to call at Collagen Matrix, and when
When Collagen Matrix changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Collagen Matrix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Collagen Matrix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Collagen Matrix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Collagen Matrix makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Polyganics?
Polyganics was acquired by Collagen Matrix. The deal was reported on October 5, 2022. Collagen Matrix, Inc. is a developer and manufacturer of collagen-based medical products used for tissue and bone repair and regeneration. Collagen Matrix is privately held and operates in Manufacturing.
When did Collagen Matrix acquire Polyganics?
Collagen Matrix's acquisition of Polyganics was reported on October 5, 2022. Collagen Matrix, Inc. ("Collagen Matrix"), a global leader in regenerative medicine and a Linden Capital Partners ("Linden") portfolio company, today announced the acquisition of Polyganics, B.V ("Polyganics"). Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Polyganics do?
Polyganics is a medical technology company with multiple versatile polymer platforms. The company develops, manufactures and commercializes innovative bioresorbable medical devices that facilitate tissue repair and regeneration. It is privately held, operating in Manufacturing.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.